| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.17 | 5e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.15 | 8e-05 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |